We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Merck Hits Impax With Patent Suit for Generic Vytorin Application
Merck Hits Impax With Patent Suit for Generic Vytorin Application
August 31, 2010
Merck has filed a patent infringement suit against Impax Laboratories after the generic-drug maker applied for FDA approval of a generic version of the blockbuster cholesterol drug Vytorin.